Post-approval studies (Phase 4)UnknownNCT05597202
What this trial is testing
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22